Cargando…

Hydroxychloroquine: small effects in mild disease

Detalles Bibliográficos
Autores principales:	Levantovsky, Rachel, Vabret, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186934/ https://www.ncbi.nlm.nih.gov/pubmed/32286537 http://dx.doi.org/10.1038/s41577-020-0315-4

Ejemplares similares

Shared CD8(+) T cell receptors for SARS-CoV-2
por: Levantovsky, Rachel, et al.
Publicado: (2020)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

Antibody responses to SARS-CoV-2 short-lived
por: Vabret, Nicolas
Publicado: (2020)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021)

When ‘mild’ COVID-19 is not so mild
por: Minton, Kirsty
Publicado: (2022)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
por: Bae, Soo Hyeon, et al.
Publicado: (2019)

A Pharmacokinetics‐Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID‐19 Pandemic
por: Scheetz, Marc H., et al.
Publicado: (2020)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?
por: Ippolito, Matthew M, et al.
Publicado: (2020)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)

Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
por: Hong, Kyung Soo, et al.
Publicado: (2020)

Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate
por: Allenzara, Astia, et al.
Publicado: (2023)

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease
por: Mallat, Jihad, et al.
Publicado: (2020)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

Rise and Fall: Hydroxychloroquine and COVID‐19 Global Trends: Interest, Political Influence, and Potential Implications
por: Englund, Tessa R., et al.
Publicado: (2020)

Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism
por: Perrella, Alessandro, et al.
Publicado: (2021)

Neutralizing antibody response in mild COVID-19
por: van der Heide, Verena
Publicado: (2020)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
por: Tang, Wei, et al.
Publicado: (2020)

Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Small wonder: nanoparticles feed hydroxychloroquine to activated neutrophils
por: NaveenKumar, Somanathapura K., et al.
Publicado: (2022)

Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Mokhtari, Majid, et al.
Publicado: (2021)

Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2021)

Coordinated and sustained immune memory responses after mild COVID-19
por: Alrubayyi, Aljawharah
Publicado: (2020)

Early prone positioning therapy for patients with mild COVID-19 disease
por: Liu, Xiaoyi, et al.
Publicado: (2021)

Early prone positioning therapy for patients with mild COVID-19 disease
por: Liu, Xiaoyi, et al.
Publicado: (2021)

The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: Mo, De-Gang, et al.
Publicado: (2022)

Adults With Mild‐to‐Moderate Congenital Heart Disease Demonstrate Measurable Neurocognitive Deficits
por: Perrotta, Melissa L., et al.
Publicado: (2020)

Relationship between Delusion of Theft and Cognitive Functions in Patients with Mild Alzheimer’s Disease
por: Na, Hae-Ran, et al.
Publicado: (2018)

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study
por: Ip, Andrew, et al.
Publicado: (2021)

Adherence to Weight‐Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Systemic Lupus Erythematosus and Rheumatoid Arthritis: Results of a Quality Improvement Initiative
por: Skorupa, Tara, et al.
Publicado: (2021)

Do rogue antibodies make the difference between mild versus severe COVID-19?
por: Flemming, Alexandra
Publicado: (2021)

Gender Specificities in Sleep Disturbances following Mild Traumatic Brain Injury: A Preliminary Study
por: Martens, Géraldine, et al.
Publicado: (2023)

Effect of mild physical activity in obese and elderly women with type 2 diabetes
por: Seshadri, Krishna G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0p2f5obkvbhis9vnpv1ougl2r5